RTA404, an Activator of Nrf2, Activates the Checkpoint Kinases and Induces Apoptosis through Intrinsic Apoptotic Pathway in Malignant Glioma

por Tai-Hsin Tsai, Ann-Shung Lieu, Tzuu-Yuan Huang, Aij-Lie Kwan, Chih-Lung Lin, Yi-Chiang Hsu
Publicado 2021

Cytotoxicity induced by carbon nanotubes in experimental malignant glioma

por Romano-Feinholz S, Salazar-Ramiro A, Muñoz Sandoval E, Magaña-Maldonado R, Hernández Pedro N, Rangel López E, González Aguilar A, Sanchez-Garcia A, Sotelo J, Pérez de la Cruz V, Pineda B
Publicado 2017

Preliminary Report: Rapid Intraoperative Detection of Residual Glioma Cell in Resection Cavity Walls Using a Compact Fluorescence Microscope

por Jiro Akimoto, Shinjiro Fukami, Megumi Ichikawa, Kenta Nagai, Michihiro Kohno
Publicado 2021

Antitumor Effect of a New Nano-Vector with miRNA-135a on Malignant Glioma [Corrigendum]

por Liang C, Sun W, He H, Zhang B, Ling C, Wang B, Huang T, Hou B, Guo Y
Publicado 2020

Antitumor effect of a new nano-vector with miRNA-135a on malignant glioma

por Liang C, Sun W, He H, Zhang B, Ling C, Wang B, Huang T, Hou B, Guo Y
Publicado 2017

Role of Polymeric Local Drug Delivery in Multimodal Treatment of Malignant Glioma: A Review

por Tseng YY, Chen TY, Liu SJ
Publicado 2021

Size-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy

por Meng Gao, Yue Chen, Chenghu Wu
Publicado 2021

Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study

por Kiwan Kim, Ho-Shin Gwak, Nayoung Han, Eun Kyung Hong, Beom K. Choi, Sangeun Lee, Soyoung Choi, Ju-Hwang Park, Ji-Hye Seok, Yeongha Jeon, Hyuntae Cho, Song-Jae Lee, Yura Lee, Ki Taek Nam, Seong-Won Song
Publicado 2021

Role of Borneol Induced Autophagy in Enhancing Radiosensitivity of Malignant Glioma

por Qinglin Li, Liang Xia, Caixing Sun, Huangjie Zhang, Mengying Zheng, Hongyan Zhang, Hongyang Lu, Zeng Wang
Publicado 2021

SEMI–MATURE DENDRITIC CELLS AS A POTENTIAL BASIS FOR THE INDUCTION OF ANTI–TUMOR RESPONSE IN PATIENTS WITH MALIGNANT GLIOMAS

por O. Yu. Leplina, M. A. Tihonova, Yu. P. Kozlov, V. V. Stupak, S. D. Nikonov, A. A. Ostanin, E. R. Chernykh
Publicado 2014